Zimbabwe's Parliamentary Women's Caucus adopted a resolution calling on the government to review the country's doctor-patient confidentiality policy in regard to HIV status.
Ads by Google
Safe Blood for Africa Foundation subsidiary, is proud to announce it has dramatically reduced the incidence of HIV infections among its members.
John Edwards unveiled a plan for combating HIV/AIDS in the U.S. and worldwide.
Ugandan President cautioned soldiers in the Uganda People's Defense Forces against "reckless" behavior that increases risk of HIV transmission.
European Commission has approved Pfizer's antiretroviral drug Celsentri, known generically as maraviroc.
Unstable and unpredictable lifestyles are significant factors in determining access to health care among low-income HIV-positive people.
The European Medicines Agency on Thursday recommended lifting a temporary European Union ban on the sale of Roche's antiretroviral drug Viracept, the AP/Forbes reports (AP/Forbes, 9/20).
HIV-positive women who become pregnant are less likely to develop AIDS or die of AIDS-related causes than HIV-positive women who do not become pregnant.
NeurogesX has completed enrollment in study C119, a second Phase 3 clinical trial of its lead product candidate NGX-4010 for the treatment of painful HIV-distal sensory polyneuropathy.
Toronto's Globe and Mail on Thursday examined efforts to develop new measurements for screening the blood of volunteers in Africa for vaccine trials for HIV/AIDS and other infectious diseases, such as malaria and tuberculosis.
Pfizer presented results of a new long-term study of its antiretroviral drug maraviroc.
PrEP could prevent as many as three million new HIV cases over 10 years in sub-Saharan Africa.
Ardea Biosciences presented the results of Phase 1 studies of RDEA806, a novel HIV non-nucleoside reverse transcriptase inhibitor.
HIV-positive women who want to become pregnant should be informed that pregnancy is safer during the early clinical stages of the virus.
Provincial and local governments in China are failing to implement national policies on HIV/AIDS.
More than 100 HIV/AIDS organizations have issued a "Call to Action" statement to all presidential candidates.
West African researchers are expressing concerns about disparities in HIV/AIDS services and prevention campaigns between rural and urban areas in the region.
Pathway Diagnostics announces nationwide availability of SensiTrop for determining the co-receptor tropism status of HIV infected patients.
Canada officials announced a new law that will require people who might have exposed emergency workers to HIV or other infectious diseases to submit a blood test.
Roche Diagnostics' newly developed, automated real-time PCR test for HIV provides shorter turnaround time and less hands-on labor than one of its main competitors.
The majority of New York City's new HIV diagnoses are among black and Hispanic men under age 30.
VOA News examined how the spread of HIV in Indonesia primarily is fueled by commercial sex work.
HIV-positive people who use pillbox organizers to help adhere to their antiretroviral drug regimens could reduce the risk of progressing to AIDS.
China's FDA will begin a new policy under which all blood products in the country will be screened for HIV.
Spanish Ministry of Health plans to determine the number of people living with HIV in the country and reduce the spread of the virus by 2015.
The AIDS Committee of Papua New Guinea's Southern Highlands province has found no evidence that people living with HIV/AIDS in the area were buried alive.
GeoVax Labs presented successful human trial results for its HIV/AIDS vaccines at the AIDS Vaccine 2007 Conference.